Optimizing bone morphogenic protein 4-mediated human embryonic stem cell differentiation into trophoblast-like cells using fibroblast growth factor 2 and transforming growth factor-beta/activin/nodal signalling inhibition

Mariann Koel; Urmo Vosa; Kaarel Krjutskov; Elisabet Einarsdottir; Juha Kere; Juha Tapanainen; Shintaro Katayama; Sulev Ingerpuu; Viljar Jaks; Ulf-Hakan Stenman; Karolina Lundin; Timo Tuuri; Andres Salumets

doi:10.1016/j.rbmo.2017.06.003

Optimizing bone morphogenic protein 4-mediated human embryonic stem cell differentiation into trophoblast-like cells using fibroblast growth factor 2 and transforming growth factor-beta/activin/nodal signalling inhibition

Mariann Koel, Urmo Vosa, Kaarel Krjutskov, Elisabet Einarsdottir, Juha Kere, Juha Tapanainen, Shintaro Katayama, Sulev Ingerpuu, Viljar Jaks, Ulf-Hakan Stenman, Karolina Lundin, Timo Tuuri, Andres Salumets

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

Originalspråk	engelska
Tidskrift	Reproductive BioMedicine Online
Volym	35
Nummer	3
Sidor (från-till)	253-263
Antal sidor	11
ISSN	1472-6483
DOI	https://doi.org/10.1016/j.rbmo.2017.06.003
Status	Publicerad - sep. 2017
MoE-publikationstyp	A1 Tidskriftsartikel-refererad

Vetenskapsgrenar

3123 Kvinno- och barnsjukdomar

Åtkomst av dokument

10.1016/j.rbmo.2017.06.003

Optimizing bone morphogenic proteinSlutlig publicerad version, 2,29 MBLicens: !!Unspecified

Citera det här

Koel, M., Vosa, U., Krjutskov, K., Einarsdottir, E., Kere, J., Tapanainen, J., Katayama, S., Ingerpuu, S., Jaks, V., Stenman, U.-H., Lundin, K., Tuuri, T., & Salumets, A. (2017). Optimizing bone morphogenic protein 4-mediated human embryonic stem cell differentiation into trophoblast-like cells using fibroblast growth factor 2 and transforming growth factor-beta/activin/nodal signalling inhibition. Reproductive BioMedicine Online, 35(3), 253-263. https://doi.org/10.1016/j.rbmo.2017.06.003

@article{7dca6bb2583341f58bdda77dca50ec92,

title = "Optimizing bone morphogenic protein 4-mediated human embryonic stem cell differentiation into trophoblast-like cells using fibroblast growth factor 2 and transforming growth factor-beta/activin/nodal signalling inhibition",

keywords = "bone morphogenic protein 4, fibroblast growth factor 2, human embryonic stem cell, placenta, transforming growth factor-beta, trophoblast cells, EXTRAVILLOUS TROPHOBLAST, BMP4, EXPRESSION, SWITCHES, FGF2, 3123 Gynaecology and paediatrics",

author = "Mariann Koel and Urmo Vosa and Kaarel Krjutskov and Elisabet Einarsdottir and Juha Kere and Juha Tapanainen and Shintaro Katayama and Sulev Ingerpuu and Viljar Jaks and Ulf-Hakan Stenman and Karolina Lundin and Timo Tuuri and Andres Salumets",

year = "2017",

month = sep,

doi = "10.1016/j.rbmo.2017.06.003",

language = "English",

volume = "35",

pages = "253--263",

journal = "Reproductive BioMedicine Online",

issn = "1472-6483",

publisher = "ELSEVIER SCI IRELAND LTD",

number = "3",

}

Koel, M, Vosa, U, Krjutskov, K, Einarsdottir, E , Kere, J , Tapanainen, J, Katayama, S, Ingerpuu, S, Jaks, V, Stenman, U-H , Lundin, K , Tuuri, T & Salumets, A 2017, 'Optimizing bone morphogenic protein 4-mediated human embryonic stem cell differentiation into trophoblast-like cells using fibroblast growth factor 2 and transforming growth factor-beta/activin/nodal signalling inhibition', Reproductive BioMedicine Online, vol. 35, nr. 3, s. 253-263. https://doi.org/10.1016/j.rbmo.2017.06.003

Optimizing bone morphogenic protein 4-mediated human embryonic stem cell differentiation into trophoblast-like cells using fibroblast growth factor 2 and transforming growth factor-beta/activin/nodal signalling inhibition. / Koel, Mariann; Vosa, Urmo; Krjutskov, Kaarel et al.
I: Reproductive BioMedicine Online, Vol. 35, Nr. 3, 09.2017, s. 253-263.

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

TY - JOUR

T1 - Optimizing bone morphogenic protein 4-mediated human embryonic stem cell differentiation into trophoblast-like cells using fibroblast growth factor 2 and transforming growth factor-beta/activin/nodal signalling inhibition

AU - Koel, Mariann

AU - Vosa, Urmo

AU - Krjutskov, Kaarel

AU - Einarsdottir, Elisabet

AU - Kere, Juha

AU - Tapanainen, Juha

AU - Katayama, Shintaro

AU - Ingerpuu, Sulev

AU - Jaks, Viljar

AU - Stenman, Ulf-Hakan

AU - Lundin, Karolina

AU - Tuuri, Timo

AU - Salumets, Andres

PY - 2017/9

Y1 - 2017/9

KW - bone morphogenic protein 4

KW - fibroblast growth factor 2

KW - human embryonic stem cell

KW - placenta

KW - transforming growth factor-beta

KW - trophoblast cells

KW - EXTRAVILLOUS TROPHOBLAST

KW - BMP4

KW - EXPRESSION

KW - SWITCHES

KW - FGF2

KW - 3123 Gynaecology and paediatrics

U2 - 10.1016/j.rbmo.2017.06.003

DO - 10.1016/j.rbmo.2017.06.003

M3 - Article

SN - 1472-6483

VL - 35

SP - 253

EP - 263

JO - Reproductive BioMedicine Online

JF - Reproductive BioMedicine Online

IS - 3

ER -

Koel M, Vosa U, Krjutskov K, Einarsdottir E , Kere J , Tapanainen J et al. Optimizing bone morphogenic protein 4-mediated human embryonic stem cell differentiation into trophoblast-like cells using fibroblast growth factor 2 and transforming growth factor-beta/activin/nodal signalling inhibition. Reproductive BioMedicine Online. 2017 sep.;35(3):253-263. doi: 10.1016/j.rbmo.2017.06.003